Skip to the main content

Review article

The new therapeutic options in the treatment of spondiloarthritides

Porin PERIĆ ; Clinic for Rheumatic Diseases and Rehabilitation Clinical Hospital Center Zagreb, Kišpatićeva 12, Zagreb


Full text: croatian pdf 95 Kb

page 104-110

downloads: 281

cite

Full text: english pdf 95 Kb

page 104-110

downloads: 325

cite


Abstract

Therapeutic options for patients suffering from the more severe forms of SpA have been rather limited. The review focuses on the new therapeutic options in treatment spondyloarthritides. There is now clearly evidence that TNF-alpha inhibitors are effective and safe agents in managing psoriathic arthritis (PsA) and ankylosing spondylitis (AS).

Keywords

biological agents; spondyloarthritides; TNF-alpha inhibitors

Hrčak ID:

129212

URI

https://hrcak.srce.hr/129212

Publication date:

28.7.2006.

Article data in other languages: croatian

Visits: 1.324 *